Sunday, March 2, 2014

Seeking Alpha: Globus Medical Staying On A Growth Track

The world of spinal care continues to be divided among the slow-growing giants like Johnson & Johnson (JNJ), Medtronic (MDT), and Stryker (SYK) and the much faster-growing up-and-comers like NuVasive (NUVA) and Globus Medical (GMED). With Globus maintaining a focus on continuous product development and new launches and the expansion of its sales effort, the growth prospects continue to look good, particularly as some industry headwinds appear to be abating.

Valuation for med-tech has gotten trickier as the stocks have been quite strong over the last year or so. Globus isn't so appealing from the viewpoint of intrinsic value (discounted cash flow), but the stock doesn't seem overpriced from the perspective of sales and EBITDA multiples.

Continue reading here:
Globus Medical Staying On A Growth Track

No comments: